CAD and coronary artery disorder: To reveal the signaling pathways behind the FIR response, RNA-seq was performed in one male (CAD178) and one female (CAD162) CAD ECFCs that showed an increase in tube formation after FIR treatment and one male (CAD222) and one female (CAD239) FIR-non/unresponsive CAD ECFCs (Fig. S2).